Glucagon analogs with ASP.sup.9 replacements or deletions
US5143902A · kind A · utility
3Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 1991 |
| Grant date | Sep 1, 1992 |
| Priority date | — |
| Expiry date | Dec 16, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Glucagon analogs characterized principally by the removal of the 9-aspartic acid residue or its replacement with an amino acid residue other than an L- dibasic amino acid containing up to five carbon atoms with or without a histidine at the amino terminal are useful adjuncts to insulin therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.